How should I manage a patient with a right upper‑lobe solid pulmonary nodule that grew from 5 mm to 9 mm over a few months and is PET‑avid, along with a new 8 mm ground‑glass nodule?

Management of Growing PET-Avid Solid Nodule with New Ground-Glass Nodule

The 9 mm PET-avid solid nodule that has grown from 5 mm over a few months requires immediate surgical resection or nonsurgical biopsy, while the new 8 mm ground-glass nodule should undergo short-term CT surveillance at 3 months.

Primary Concern: The Growing Solid Nodule

Your dominant solid nodule demonstrates three high-risk features that mandate aggressive intervention:

• Documented growth from 5 mm to 9 mm over several months (clear evidence of malignant growth pattern) 1
• PET-avidity indicating intense metabolic activity 1
• Size >8 mm placing it in the high-risk category 1

Recommended Action for Solid Nodule

Proceed directly to surgical diagnosis via thoracoscopy for diagnostic wedge resection 1. This is the appropriate next step because:

• When a solid nodule >8 mm is intensely hypermetabolic by PET, surgical diagnosis is recommended 1
• Solid nodules showing clear evidence of malignant growth on serial imaging warrant nonsurgical biopsy and/or surgical resection unless specifically contraindicated 1
• The clinical probability of malignancy is high (>65%) given the combination of growth, PET-avidity, and size 1

Alternative approach: If surgical risk is high or patient preference favors tissue diagnosis first, nonsurgical biopsy (transthoracic needle biopsy or bronchoscopy) is acceptable 1. However, understand that a nondiagnostic biopsy result does not exclude malignancy and would still require surgical resection.

Secondary Concern: The New 8 mm Ground-Glass Nodule

The 8 mm ground-glass nodule requires a different management strategy because ground-glass nodules behave distinctly from solid nodules, even when malignant.

Recommended Action for Ground-Glass Nodule

Obtain repeat CT at 3 months to determine persistence 1. Here's why this measured approach is appropriate:

• Ground-glass nodules >5 mm require surveillance, but many resolve spontaneously if infectious 1
• The 3-month follow-up distinguishes transient inflammatory lesions from persistent lesions requiring longer surveillance 1
• If the nodule persists at 3 months and measures >10 mm, consider nonsurgical biopsy and/or surgical resection 1
• If persistent but stable, continue annual surveillance for at least 3 years 1

Critical caveat: Ground-glass nodules that grow or develop a solid component are often malignant and prompt further evaluation and/or resection 1. The 3-month scan will establish a new baseline for this nodule.

Managing Multiple Nodules: Key Principles

When confronted with multiple nodules during evaluation, evaluate each nodule individually rather than assuming the additional nodule is either metastatic or benign 1. The evidence strongly supports this approach:

• In screening studies, >50% of patients with one malignant nodule had additional nodules, and >85% of secondary nodules were benign 1
• The guidelines explicitly recommend that each nodule be evaluated individually and curative treatment not be denied unless there is histopathological confirmation of metastasis 1

Practical Algorithm

1. Immediate priority: Address the 9 mm PET-avid growing solid nodule with surgical resection (preferred) or biopsy
2. Concurrent planning: Schedule 3-month follow-up CT for the 8 mm ground-glass nodule
3. Staging consideration: If the solid nodule proves malignant at surgery, the ground-glass nodule's behavior over 3 months will inform whether it represents:
   • A second primary malignancy (if persistent and growing)
   • An inflammatory/infectious process (if resolved)
   • An indolent adenocarcinoma in situ (if persistent but stable)

Common Pitfalls to Avoid

Do not delay intervention on the solid nodule while surveilling the ground-glass nodule. The solid nodule's rapid growth (4 mm over several months) and PET-avidity indicate aggressive biology requiring immediate action 1.

Do not use PET to characterize the ground-glass nodule. PET has limited utility for ground-glass lesions and is not recommended 1.

Do not assume the ground-glass nodule is metastatic disease from the solid nodule without histopathological confirmation. This assumption could inappropriately deny curative treatment 1.

Do not perform biopsy of the ground-glass nodule initially. Nonsurgical biopsy of ground-glass nodules has limited sensitivity and negative predictive value 1. CT surveillance is the appropriate initial approach.